{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:09:19Z","timestamp":1780614559055,"version":"3.54.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.antiviral.2018.06.012","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T01:49:14Z","timestamp":1529545754000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17\u202fT cell subsets and CD4 + T lymphocytes with cytotoxic potential"],"prefix":"10.1016","volume":"157","author":[{"given":"Suvi","family":"Heinim\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Vesikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Blazevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.06.012_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061101","article-title":"Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore","volume":"8","author":"Aiyegbo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.06.012_bib2","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","article-title":"Characterization of CD4(+) CTLs ex vivo","volume":"168","author":"Appay","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","article-title":"Cytotoxic CD4 T cells in viral hepatitis","volume":"13","author":"Aslan","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.06.012_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.06.012_bib5","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.vaccine.2015.03.080","article-title":"Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice","volume":"33","author":"Badillo-Godinez","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.06.012_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0016-5085(97)70083-0","article-title":"Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines","volume":"113","author":"Bass","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.antiviral.2018.06.012_bib8","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1016\/j.vaccine.2011.08.026","article-title":"Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis","volume":"29","author":"Blazevic","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.06.012_bib9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/21645515.2015.1099772","article-title":"Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine","volume":"12","author":"Blazevic","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.06.012_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/21645515.2015.1099772","article-title":"Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine","volume":"12","author":"Blazevic","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.06.012_bib11","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1128\/JVI.01727-07","article-title":"Differential requirements for T cells in virus like particle- and rotavirus-induced protective immunity","volume":"82","author":"Blutt","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib12","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.1128\/JVI.07172-11","article-title":"Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection","volume":"86","author":"Brown","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.272.5258.104","article-title":"Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity","volume":"272","author":"Burns","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.06.012_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/viro.1997.8552","article-title":"Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge","volume":"232","author":"Choi","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib15","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1128\/JVI.73.9.7574-7581.1999","article-title":"Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein","volume":"73","author":"Choi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib16","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1128\/JVI.00927-06","article-title":"Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion","volume":"80","author":"Corthesy","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib17","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1128\/JVI.65.11.5928-5932.1991","article-title":"Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice","volume":"65","author":"Dharakul","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3892\/etm.2015.2511","article-title":"Changes in the cytokine expression of peripheral Treg and Th17 cells in children with rotavirus enteritis","volume":"10","author":"Dong","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.antiviral.2018.06.012_bib19","series-title":"Fields Virology","first-page":"1347","article-title":"Rotaviruses","author":"Estes","year":"2013"},{"key":"10.1016\/j.antiviral.2018.06.012_bib20","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/viro.1997.8843","article-title":"Immunity to rotavirus in T cell deficient mice","volume":"238","author":"Franco","year":"1997","journal-title":"Virology"},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2018.06.012_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1099\/0022-1317-75-3-589","article-title":"Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins","volume":"75","author":"Franco","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/viro.2002.1648","article-title":"Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses","volume":"302","author":"Ghosh","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2018.06.012_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.181.2.713","article-title":"T cell genetic background determines default T helper phenotype development in vitro","volume":"181","author":"Hsieh","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2018.06.012_bib26","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib27","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1128\/JVI.00450-08","article-title":"Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection","volume":"82","author":"Jiang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib28","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2018.06.012_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.161.1.1","article-title":"Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies","volume":"161","author":"Kipps","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2018.06.012_bib31","first-page":"687","article-title":"Activation of mouse complement by different classes of mouse antibody","volume":"38","author":"Klaus","year":"1979","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01309778","article-title":"Inhibition of in vitro reconstitution of rotavirus transcriptionally active particles by anti-VP6 monoclonal antibodies","volume":"135","author":"Kohli","year":"1994","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib33","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4161\/hv.25249","article-title":"Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles","volume":"9","author":"Lappalainen","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.06.012_bib34","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.4161\/hv.28858","article-title":"Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo","volume":"10","author":"Lappalainen","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2018.06.012_bib35","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00705-015-2461-8","article-title":"Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine","volume":"160","author":"Lappalainen","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib36","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s00705-016-2991-8","article-title":"Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins","volume":"161","author":"Lappalainen","year":"2016","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/emboj\/20.7.1498","article-title":"Structural polymorphism of the major capsid protein of rotavirus","volume":"20","author":"Lepault","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2018.06.012_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-009-0191-2","article-title":"Th17 cytokines and vaccine-induced immunity","volume":"32","author":"Lin","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib39","doi-asserted-by":"crossref","first-page":"9171632","DOI":"10.1155\/2016\/9171632","article-title":"Rotavirus recombinant VP6 nanotubes act as an immunomodulator and delivery vehicle for norovirus virus-like particles","volume":"2016","author":"Malm","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.antiviral.2018.06.012_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2016.08.009","article-title":"Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein","volume":"78","author":"Malm","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/cei.12977","article-title":"Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs","volume":"189","author":"Malm","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2017.12.009","article-title":"Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes","volume":"36","author":"Malm","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.06.012_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JVI.76.2.560-568.2002","article-title":"CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)","volume":"76","author":"McNeal","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib44","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1016\/j.vaccine.2007.05.065","article-title":"Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge","volume":"25","author":"McNeal","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.06.012_bib45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/vim.2007.0055","article-title":"IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein","volume":"20","author":"McNeal","year":"2007","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2007.01.041","article-title":"Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB\/c mice","volume":"363","author":"McNeal","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fcgamma receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2018.06.012_bib48","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.12688\/f1000research.11912.1","article-title":"Rotavirus Vaccines: a story of success with challenges ahead","volume":"6","author":"O'Ryan","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.antiviral.2018.06.012_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0042-6822(87)90328-X","article-title":"In vitro assembly of bovine rotavirus nucleocapsid protein","volume":"157","author":"Ready","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib50","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/JCM.28.9.1891-1897.1990","article-title":"Homotypic serum antibody responses to rotavirus proteins following primary infection of young children with serotype 1 rotavirus","volume":"28","author":"Richardson","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib51","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00705-013-1916-z","article-title":"Understanding internalization of rotavirus VP6 nanotubes by cells: towards a recombinant vaccine","volume":"159","author":"Rodr\u00edguez","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib52","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1128\/JVI.01877-06","article-title":"Association of gamma interferon and Interleukin-17 production in intestinal CD4 super(+) T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G)","volume":"81","author":"Smiley","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib53","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/0022-1317-68-3-643","article-title":"Serum antibody responses to individual viral polypeptides in human rotavirus infections","volume":"68","author":"Svensson","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib54","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1099\/0022-1317-68-7-1993","article-title":"Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1)","volume":"68","author":"Svensson","year":"1987","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","article-title":"CD4 CTL, a cytotoxic subset of CD4+T cells, their differentiation and function","volume":"8","author":"Takeuchi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2011.03516.x","article-title":"A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles","volume":"135","author":"Tamminen","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070409","article-title":"Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice","volume":"8","author":"Tamminen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.06.012_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/vim.2015.0141","article-title":"Mucosal antibodies induced by intranasal but not intramuscular immunization block norovirus GII.4 virus-like particle receptor binding","volume":"29","author":"Tamminen","year":"2016","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/viro.1997.8762","article-title":"Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis","volume":"237","author":"Tang","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.06.012_bib60","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children","volume":"62","author":"Tate","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.06.012_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jmbi.2000.4479","article-title":"Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view","volume":"307","author":"Thouvenin","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib62","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1128\/JVI.80.10.4949-4961.2006","article-title":"Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6\/LT(R192G) or orally with live rhesus rotavirus vaccine candidates","volume":"80","author":"VanCott","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.06.012_bib63","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood-2003-08-2765","article-title":"Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection","volume":"103","author":"Zaunders","year":"2004","journal-title":"Blood"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218301748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218301748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T21:46:07Z","timestamp":1604439967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218301748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":63,"alternative-id":["S0166354218301748"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17\u202fT cell subsets and CD4+ T lymphocytes with cytotoxic potential","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}